Ultragenyx Pharmaceutical Inc.

05/01/2025 | Press release | Archived content

Eric Crombez, M.D. Appointed to Massachusetts’ Rare Disease Advisory Council

Ultragenyx Pharmaceutical Inc. published this content on May 01, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 05, 2025 at 11:49 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io